These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 1369695)

  • 1. Can virostatic chemotherapy and/or adoptive allogeneic immunotherapy eradicate in vivo Friend's virus infection?
    Mathé G; Trabaud M; Chenu E; Bourut C
    Biomed Pharmacother; 1990; 44(1):57-9. PubMed ID: 1369695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virostatic in vivo effect of elliptinium on Friend's retrovirus (a model for HIV infection).
    Mathé G; Chenu E; Bourut C
    Biomed Pharmacother; 1990; 44(1):1-3. PubMed ID: 1369686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combinations of three or four HIV virostatics applied in short sequences which differ from each other by drug rotation. Preliminary results of the viral loads and CD4 numbers.
    Mathé G; Morette C; Hallard M; Blanquet D
    Biomed Pharmacother; 1997; 51(10):417-26. PubMed ID: 9863499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AIDS therapy with two, three or four agent combinations, applied in short sequences, differing from each other by drug rotation. I. First of two parts: a phase I trial equivalent, concerning five virostatics: AZT, ddI, ddC, acriflavine and an ellipticine analogue.
    Mathé G; Pontiggia P; Orbach-Arbouys S; Triana K; Ambetima N; Morette C; Hallard M; Blanquet D
    Biomed Pharmacother; 1996; 50(5):220-7. PubMed ID: 8949403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypothetical reasons of the HIV1-AIDS "tritherapy" failure. A challenging model.
    Mathé G
    Biomed Pharmacother; 1997; 51(10):413-6. PubMed ID: 9863498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New lipophilic alkyl/acyl dinucleoside phosphates as derivatives of 3'-azido-3'-deoxythymidine: inhibition of HIV-1 replication in vitro and antiviral activity against Rauscher leukemia virus infected mice with delayed treatment regimens.
    Schwendener RA; Gowland P; Horber DH; Zahner R; Schertler A; Schott H
    Antiviral Res; 1994 May; 24(1):79-93. PubMed ID: 7944315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AZT demonstrates anti-HIV-1 activity in persistently infected cell lines: implications for combination chemotherapy and immunotherapy.
    Pincus SH; Wehrly K
    J Infect Dis; 1990 Dec; 162(6):1233-8. PubMed ID: 2230256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elliptinium, norcantharidin and tetrachlordecaoxide in combined chemo-immunotherapy prolong the survival of Friend-virus-infected mice.
    Liu XH; Blazsek I; Breard J; Comisso M; Mathe G; Misset JL
    Drugs Exp Clin Res; 1991; 17(9):419-26. PubMed ID: 1822434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy of minimal residual disease by immunocompetent lymphocytes and their activation by cytokines.
    Slavin S; Ackerstein A; Weiss L; Nagler A; Or R; Naparstek E
    Cancer Invest; 1992; 10(3):221-7. PubMed ID: 1581831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of synergistic response to combinations containing AZT in AZT-resistant HIV-1.
    Cox SW; Albert J; Wahlberg J; Uhlén M; Wahren B
    AIDS Res Hum Retroviruses; 1992 Jul; 8(7):1229-34. PubMed ID: 1520536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transmitted human immunodeficiency virus type 1 carrying the D67N or K219Q/E mutation evolves rapidly to zidovudine resistance in vitro and shows a high replicative fitness in the presence of zidovudine.
    García-Lerma JG; MacInnes H; Bennett D; Weinstock H; Heneine W
    J Virol; 2004 Jul; 78(14):7545-52. PubMed ID: 15220429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of spontaneous leukemia in AKR mice with chemotherapy, immunotherapy, or interferon.
    Bekesi JG; Roboz JP; Zimmerman E; Holland JF
    Cancer Res; 1976 Feb; 36(2 pt 2):631-9. PubMed ID: 1082796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adoptive immunochemotherapy of a transplantable AKR leukemia (K36).
    Putman DL; Kind PD; Goldin A; Kende M
    Int J Cancer; 1978 Feb; 21(2):230-3. PubMed ID: 24004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATP binding cassette multidrug transporters limit the anti-HIV activity of zidovudine and indinavir in infected human macrophages.
    Jorajuria S; Dereuddre-Bosquet N; Becher F; Martin S; Porcheray F; Garrigues A; Mabondzo A; Benech H; Grassi J; Orlowski S; Dormont D; Clayette P
    Antivir Ther; 2004 Aug; 9(4):519-28. PubMed ID: 15456083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of nucleoside-resistant variants of HIV-1 by in vitro selection in the presence of AZT or DDI but no by combinations.
    Gao Q; Parniak MA; Gu Z; Wainberg MA
    Leukemia; 1992; 6 Suppl 3():192S-195S. PubMed ID: 1602823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic drug interactions of an HIV-1 protease inhibitor with AZT in different in vitro models of HIV-1 infection.
    Lambert DM; Bartus H; Fernandez AV; Bratby-Anders C; Leary JJ; Dreyer GB; Metcalf BW; Petteway SR
    Antiviral Res; 1993 Aug; 21(4):327-42. PubMed ID: 7692816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syngeneic adoptive immunotherapy and chemoimmunotherapy of a Friend leukemia: requirement for T cells.
    Berenson JR; Einstein AB; Fefer A
    J Immunol; 1975 Jul; 115(1):234-8. PubMed ID: 1080165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing zidovudine efficacy when administered at early stages of Friend virus infection in mice.
    Sinet M; Desforges B; Launay O; Colin JN; Pocidalo JJ
    Antiviral Res; 1991 Sep; 16(2):163-71. PubMed ID: 1799277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pro-drug of zidovudine with enhanced efficacy against human immunodeficiency virus.
    Gogu SR; Aggarwal SK; Rangan SR; Agrawal KC
    Biochem Biophys Res Commun; 1989 Apr; 160(2):656-61. PubMed ID: 2719688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of 3'azido-3'deoxythymidine-resistant HIV-1 infection by dehydroepiandrosterone in vitro.
    Yang JY; Schwartz A; Henderson EE
    Biochem Biophys Res Commun; 1994 Jun; 201(3):1424-32. PubMed ID: 8024587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.